JL
Therapeutic Areas
Dexcom Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Dexcom G7 CGM | Type 1 and Type 2 Diabetes | Commercial |
| Dexcom G7 15 Day | Type 1 and Type 2 Diabetes | Commercial |
| Stelo Glucose Biosensor | Over-the-counter metabolic health monitoring | Commercial |
Leadership Team at Dexcom
JS
Jereme Sylvain
EVP, Chief Financial Officer
JC
Jon Coleman
EVP, Chief Commercial Officer
GN
Girish Naganathan
EVP, Chief Technology Officer
MB
Michael Brown
EVP, Chief Legal Officer
DA
Donald Abbey
EVP, Global Business Services, Regulatory, Medical and Clinical Affairs
MD
Matthew Dolan
EVP, Strategy & Corporate Development
SS
Sadie Stern
EVP, Chief Human Resources Officer
KS
Kevin Sayer
Chairman of the Board
SR
Steven R. Altman
Board Director
EA
Euan Ashley
Board Director